Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
As of April 7, 2026, Collegium Pharmaceutical Inc. (COLL) trades at $32.76, posting a modest 0.52% gain on the day. This analysis examines key technical levels, recent trading context, and potential near-term scenarios for the specialty pharmaceutical firm, which focuses on developing and commercializing prescription pain management therapies. No recent earnings data is available for COLL as of this writing, so market focus has been largely on technical price action and broader sector trends in
What technical signals show for Collegium (COLL) Stock | Price at $32.76, Up 0.52% - Community Risk Signals
COLL - Stock Analysis
3108 Comments
1294 Likes
1
Natanael
Power User
2 hours ago
Too late to take advantage now. 😔
👍 287
Reply
2
Tranyce
Elite Member
5 hours ago
I’m officially impressed… again. 😏
👍 80
Reply
3
Levin
Consistent User
1 day ago
Ah, such bad timing.
👍 201
Reply
4
Herrick
Engaged Reader
1 day ago
The market is consolidating near key price levels, waiting for further catalysts to drive direction.
👍 257
Reply
5
Morad
Returning User
2 days ago
Short-term price swings indicate selective investor activity, highlighting sectors with the strongest performance.
👍 203
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.